当前位置:循环首页>正文

[ESC2009]PCI治疗与CTO病变:Lim Soo Teik教授专访

作者:国际循环网   日期:2009/9/1 11:56:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

您认为PCI对CTO患者临床远期预后有何影响?PCI是如何改善患者预后的?有和循证证据?影响接受PCI的CTO患者的远期预后的因素都有哪些?药物洗脱支架对于CTO病变的应用可以改善临床预后吗?对于CTO病变的介入治疗,技术难度高,手术成功率低是否是影响预后的主要因素?

International Circulation:  What improvements in clinical outcome result in patients with STO who undergo PCI?

ST Lim:  If properly selected and with indication, we hope to actually reduce the symptoms of chest pain in patients who experience and reduce the number of medications that they need to consume to control their symptoms.  And also to improvement the pumping action of the heart and the ejection fraction, and improve the quality of life and hopefully in certain patients we can prolong their survival, especially those with large area of ischemia of the heart muscle. 


International Circulation:  What is the mechanism for improved clinical outcome in patients with CTO who undergo PCI? Is there any evidence based medicine to support it?

ST Lim:  Yeah, it is indirect.  It is first from the relief of ischemia that we hope that electrically the marker is more stable and less prone to arrthymia.  By relieving the ischemia, the hibernating marker then may improve and then contribute to the overall improvement in the left ventricle function.  And also if the artery has opened up, may be able to serve as a source of a provider to other arteries which may block off in the future. 


International Circulation:  What can affect clinical outcome in patients with CTO?

ST Lim:  Clinical outcome, it depends.  It depends on the successful performance of the revascularization and whether they have complications and of course the ejection fraction of the patient as well as the other co morbidities of the patient.


International Circulation:  So normal complications?

ST Lim:  Yes


International Circulation: What can affect clinical outcome in patients with CTO

ST Lim:  Yes if we can actually successfully revascularize the CTO with an implantation of the XXX it has been shown in several studies that it reduces the risk of restenosis and as you can see in one of the slides the artery will reocclude, then it serves as deterioriation of left ventricle function.


International Circulation:  The procedure of PCI in patients with CTO is very difficult, and the success rate is not high. Is the low success rate of PCI a primary factor affecting clinical outcome?

ST Lim:  Yes, that is one of the reasons for a not so favourable clinical outcome.  And not just a low success rate, sometimes there is a higher complication rate that they experienced.  So therefore the CTO intervention is best done in more experienced center by more experienced operators with proper selection criteria and with all the tools available.


International Circulation:  When done correctly, the success rate is higher.

ST Lim:  Yes, higher success rate.  Many centres how achieve a success rate of 90% or more, that is possible.
 


 

S T Lim教授简介
 
Dr Lim Soo Teik
National Heart Centre Singapore
Head & Senior Consultant, Department of Cardiology
Director, Interventional Cardiology
MBBS, MMed (Internal Medicine), MRCP (UK), FRCP (Edin), FAMS

 

版面编辑:杨新象



Lim Soo TeikPCICTO

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530